Cavanagh Bethany J's Form 4 filing
Beam Therapeutics Inc. (BEAM) · filed Oct 2, 2024
- Accession no.
- 0000950170-24-111737
- Filed
- Oct 2, 2024
- Trade date
- Sep 30-Oct 1, 2024
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market sales total $6.79K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Cavanagh Bethany JCIK 0002033155 | Officer (SVP, Finance and Treasurer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 30, 2024 | Common Stock | AGrant or awardAcquired | +2,500 | $0.00 | $0 | 45,220 | Direct | |
| Oct 1, 2024 | Common Stock | SSaleDisposed | −289 | $23.48 | −$6,785.72 | 44,931 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.